OT: Stock and Investment Thread
- Thread starter RU05
- Start date
Price targets raised to the $430 to $450 range. It was an outstanding report. AVGO will be back over $400 in a week or so.
Agreed - this selloff is absurd unless you believe there are 'big money' reasons to "tank it" for a quick money grab on the short play or a reset going into next year. The earnings report was outstanding and this thing will be up near $500 next year. .
Another rug pull on legalization or rescheduling or is this one finally real? If real, TLRY et al have a lot of room to run.
UPDATE: Bought a block of TLRY shares just before the bell. Saw the CNBC article that Trump is likely to sign executive orders for reclassification. Maybe legalization in 2026? I'm using my Fidelity rollover IRA, so I can trade as needed (without tax implications). We shall see!
@rurahrah000
Last edited:
Actually, nothing real. A fake report of an FDA denial was posted on a Yahoo Finance page. It triggered automated selling, but then everyone figured out the info was BS. The stock gained most of the dump back.
FDA news should post sometime on Monday.
Approved!!!
Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) | Milestone Pharmaceuticals, Inc.
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT enables development of AFib-RVR under sNDA pathway Milestone well-capitalized to launch and
investors.milestonepharma.com
AMEN! This is going to be interesting on Monday and over the next few weeks. Cardamyst was approved for PSVT which is a relatively smaller patient population. However, the next indication they are working on is A-FIB, which is huge. Getting PSVT approved will now give the street much more confidence that A-FIB is within reach and likely cause a re-rating of the stock.Approved!!!
Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) | Milestone Pharmaceuticals, Inc.
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT enables development of AFib-RVR under sNDA pathway Milestone well-capitalized to launch and
I am holding MIST Dec 19 $2.5 calls.....which I will probably cash in on Monday. However, not sure what to do with my shares. Hold, trim, or sell. Hmm.....
The 2 indications (one approved, one in development):
Last edited:
Whoever posted it should go to prison it triggered my stop loss. Hello SEC?!?
+1
I'm sure it messed up a bunch of investors. Seemed deliberate, especially on a day of heavy options trading.
Not too much right now on SLS, need to research more. Based on what I know, the AML space is very crowded, but if you can show legit improvement, the market is huge and lucrative (so high risk, high reward). Also, it seems like they will need to raise again in early/mid-2026, so perhaps wait for the dilution dip to buy (or add)?
Phase 2 update coming around this time, so maybe good news and the raise would be announced at the same time? Something to look into.
One last thing, SJS' market cap of $300m is perfect for clinical stage biotech. Not too low that the company is in distress, but not too high that the initial value is already sucked up. Very interesting opportunity!
It's all about that Beta.Junior copper miners? Young man, you have a problem.
Then again, I'm waiting for the FDA decision today or Monday on MIST, so we all have our burden to bear.
My new GLD futures already blowing up!
AVGO = price targets are increasing, major intraday turnaround?
Autonomous.
Rivian unveils ambitious plan to take on autonomous driving
The company’s first step is to bring its Universal Hands-Free system to its second-generation R1 trucks and SUVs, which first rolled off lots in 2024.
www.detroitnews.com
"Electric-vehicle maker Rivian Automotive Inc. unveiled plans to bring more autonomous driving features to its electric vehicles, potentially upending conventional rules of car use and ownership.
At an event in Palo Alto, California, on Thursday, CEO RJ Scaringe laid out the company’s road map, which involves delivering enhanced driver assistance tools to existing vehicles in the coming weeks, followed by a more pronounced technical push throughout 2026 to make future EV models capable of driving without human intervention."
I was able to get in on TLRY at $12.2.....should have bought calls instead.
Is TLRY your preferred cannabis play? Seems like the bellwether of the group.